コスモス・ヘルスのニュース一覧

Cosmos Health Offering Stock, Together With Warrants

Dow Jones12/19 07:06

Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price

Accesswire11/26 22:30

Biden Proposes Medicare, Medicaid Coverage of Obesity Drugs

BNN Bloomberg11/26 18:41

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

Accesswire11/18 21:00

Cosmos Health Third Quarter 2024 Earnings: Misses Expectations

Yahoo Finance11/17 20:30

Earnings Flash (COSM) COSMOS HEALTH Reports Q3 Revenue $12.4M

MT Newswires11/15 23:22

コスモス・ヘルス | 10-Q：Q3 2024 四半期報告書

SEC11/15 05:56

Cosmos Health Sees FY27 Revenue To Increase By 163%, From $59.35M In 2024 To $155.80M In 2027; Gross Profit To Grow By 653%, From $6.25M In 2024 To $47.06M In 2027; Gross Profit Margin To Expand By 1,970 Basis Points, From 10.50% In 2024 To 30.20% In...

Benzinga11/13 01:08

Cosmos Health Issues Letter to Shareholders

Accesswire11/13 01:00

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, With Gross Profit Rising 21%

Accesswire11/02 00:30

Cosmos Health Files Secondary Offering of Shares

Seeking Alpha10/29 05:49

Cosmos Health Reports Robust Sales of Proprietary Brands on Amazon UK

Seeking Alpha09/25 23:01

Cosmos Health Reports 160% Increase In 2024 YTD Sales Of Proprietary Brands On Amazon UK, Reaching $596K Compared To $230K In 2023

Benzinga09/25 21:28

Cosmos Health Gets Over $500,000 in UK Initial Orders for Antimicrobial Wash

MT Newswires09/24 01:30

Cosmos Health Receives Initial Orders Exceeding $500,000 For C-Scrub In The UK; Future Orders Booked At Accelerated Pace With Strong Profitability Anticipated Due To High Profit Margins

Benzinga09/24 00:59

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, With a Market Size Valued at Over $37.5 Billion

Accesswire09/20 03:40

Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

Accesswire09/19 01:30

Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price

Accesswire09/17 23:45

Cosmos Health Secures Exclusivity Agreement With Virax Biolabs to Distribute Mpox PCR Kits Across the GCC, Including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Accesswire09/16 20:30

EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East

Benzinga08/28 19:16